He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...

It’s no easy gig analysing share prices and company performance but somebody’s got to do it. This week, two of ... Read More ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...

Moderna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 ...